Most Common Treatments For Heart Failure

The prevalence of congestive heart failure is on the increase both in the United States and all over the world, and it is the leading cause of hospitalization in the elderly population. Congestive heart failure is a progressive disease generally seen in the elderly, which if not properly managed, can lead to repeated hospital admissions or death. Heart failure means that the heart muscle is weakened. A weakened heart muscle may not be strong enough to pump an adequate amount of blood out of its chambers. To compensate for its diminished pumping capacity, the heart may enlarge. Commonly, the heart's pumping inefficiency causes a buildup of blood in the

Beta-blockers have been recently reported to decrease mortality in heart failure patients. Mortality and hospitalization rates for patients with the disease are high and continue to rise. Despite the magnitude of the problem, treatment of congestive heart failure is often inadequate. Primary care physicians care for most patients with heart failure. Beta-blocker therapy is appropriate in patients with NYHA class II or class III symptoms resulting from left ventricular systolic dysfunction. Unless contraindicated, beta-blockers should be considered a mainstay of therapy in these patients to improve symptoms and mortality and to decrease hospitalizations. Beta-blockers should not be administered to patients with heart failure who have bradycardia, heart block or hemodynamic instability.

Congestive heart failure (CHF) is a situation where the heart is not able to pump adequate blood to the other organs of the body. Causes of CHF are coronary artery disease, past myocardial infarction, hypertension, heart valve disease, cardiomyopathy, congenital heart defects, endocarditis and myocarditis (American heart association, 2013) .In the case scenario of Mr. P 76 year old man comes with the history of cardiomyopathy and CHF and in the past repeatedly admitted for the management of CHF symptoms. This essay discusses about approach to care, treatment plan, patient and family education and teaching plan that is given to Mr.P.

Congestive heart failure (CHF) is a syndrome that occurs when the heart cannot pump sufficient blood to meet the tissues metabolic and oxygen needs. As a result, intravascular/ interstitial volume overload and poor tissue perfusion occurs. An individual with heart failure experiences reduced exercise tolerance, a reduced quality of life and shortened life span. The most common cause of heart failure is coronary artery disease (CAD). The incidence of heart failure increases with age. Approximately 1% of people over the age of 50 and 10% of people over the age of 80 experience heart failure. The prognosis depends on underlying cause and response to treatment. Heart failure may be classified according to the side of the heart affected.

Pharmacological treatments with diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or aldosterone antagonist, and beta-blockers are essential for the treatment of heart failure and are effective in improving symptoms of heart failure and patient well-being. Diuretics are administered to help get rid of the excess fluid that helps improve breathing associated with shortness of breath, at rest or on exertion. Diuretics provide relief from symptoms and signs of pulmonary and venous congestion by promotion of fluid loss through the kidneys. Diuretics, for example, Furosemide helps improve breathing status, but monitoring patients for dehydration and kidney problems is crucial. Patient education is essential to ensuring medication adherence and early identification of adverse effects and potential for drug interactions.

stem cells. Any damage to tissues or organs can be grown again, including heart muscles to fix

Heart failure is mostly caused by other medical conditions that weaken the heart. These include coronary artery disease, hypertension,

In order to obtain relevant information to support this topic, databases including PubMed, Medline, UpToDate, and Google Scholar were used. Terms used in each search included and combined the following: mesenchymal stem cell, cardiac stem cells, HF, heart repair, ejection fraction, cardiac output, cardiac index, mortality.

Congestive heart failure (CHF) is a commonly seen in the hospital setting. CHF results in patients having difficulty breathing and can go in to respiratory arrest. There is decreased cardiac output and labs will show increased BNP. Patients who have CHF history will have chest x-ray and EKG. Therapy for CHF is to correct the abnormal labs and keep the patient from arresting and being placed on a vent. This paper will look at the molecular make up of CHF all the way to how to take care of the patient with advanced CHF. Patients are placed on medications to help with fluid overload and blood pressures. At times patients may have to be placed on cardiac drips. Patients with CHF are prone to pulmonary complications such as pulmonary edema, and

of the study is to determine the benefits and safety of the drug called Liraglutide in patients with

Another study by Dedkov et al demonstrated that mice with STEMI when treated with Ivabradine had improved ejection fraction, coronary reserve and the amount of interstitial and periarteriolar collagen indicating that this agent might be useful in preventing remodeling of heart (46). A pilot study of 124 patients investigating the role of Ivabradine in successfully reperfused STEMI patients demonstrated promising results with a smaller increase in LV end-diastolic volume index (p=0.04), and significant improvement in LV ejection fraction compared with the control group (p=0.04)

After patients have gone through heart disease, like any other injury, therapeutic steps must be taken. Therapy and rehabilitation of damaged hearts has been improved through the utilization of stem cells. Therapy includes strengthening of the damaged area as to prevent the incident from reoccurring and getting the patient back to their normal life. Scientists, again, used rats that had had induced myocardial infarctions. This

Almost 6 million Americans are living with heart failure, and over 900,000 new cases are diagnosed each year. Heart failure isn’t as bad as it sounds, it does not mean your heart has failed or stopped beating. It means that your heart, a muscle that pumps blood to the different parts of your body, is not working as well as it should be and it cannot pump as much blood as your body needs. As your heart's pumping action lessens, blood may clog in your lungs, liver, or legs. This can cause shortness of breath, leg swelling (it is called

Pluripotent stem cells can differentiate into cardiomyocytes in vitro and in vivo. However, their efficacy results in a decreased safety. Pluripotent stem cells have unlimited potential to proliferate and phenotypic heterogeneity, which results in an increased risk of tumour formation. Immature stem cells are also electrically unstable, which can cause arrhythmia in the heart, as cardiac muscle is self-excitable. Regardless, pluripotent cells are considered one of the most promising sources for organ regeneration

Scientists from the Cedars-Sinai Heart Institute in Los Angeles CA: highlighted the need for stem therapy in replacing aging heart muscles using rats (Paddock, 2017). The induced cells were able to grow and multiply thus repair the heart muscles of the older rats to improve the general body functioning.